Analysis of the Current Trend and Pipeline Opportunities in the Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, and Immunotherapy and Vaccines Markets, Including Current Products such as Patanase, Dymista, Nasonex, Allegra, and Staloral with Assessment of Key Companies in the Allergic Rhinitis Market Including GSK and Merck & Co.
What can be expected from the Allergic Rhinitis Drugs Market? Which areas are going to grow at the fastest rates? This Visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects.
Our 240-page report provides 173 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across the all the major categories of the allergic rhinitis drugs market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.
Forecasts from 2016-2026 and other analyses show you commercial prospects Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter’s Five Forces analysis) and commercial developments.
See revenue forecasts for the leading submarkets and indications How will submarkets perform to 2026? Our study forecasts revenues in the following Allergic Rhinitis Drugs submarkets: • Intranasal Anthistamines • Intranasal Corticosteroids • Oral Antihistamines • Immunotherapy and Vaccines
See detailed profiles or revenue forecasts for some the leading products in the market How will leading drugs perform to 2026? Our study provides detailed profiles or forecasts revenues for a number of drugs in the allergic rhinitis drugs market including: • Patanase • Astepro • Astelin • Dymista • Nasonex • Avamys • Veramyst • Flixonase • Rhinocort • Omnaris • Nasacort • Beconase • Qnasl • Zetonna • Allegra • Zyrtec • Claritin • Xyzal • Allelock • Clarinex • Ebastel • Talion • Staloral • Alutard SQ • Grazax • Ragwitek
See revenue forecasts for the leading international markets How will leading national and regional markets perform to 2026? Our study forecasts revenues in national markets including products, including: • US • EU5 – Germany, UK, France, Italy and Spain • China • Japan • India • Russia • Brazil
Leading companies and potential for market growth Visiongain forecasts overall revenue for the Allergic Rhinitis Drugs Market will reach $16,500m in 2026. We predict a high revenue growth over the forecast period driven by an urbanisation, climate change, increasing patient expectations and a higher incidence of allergic rhinitis symptoms, rapid growth of emerging economies and emerging allergic rhinitis drug technologies.
Our work analyses the key companies in the market. See Visiongain’s analysis of six leading companies, including these: • GSK • Merck & Co • Sanofi • Johnson & Johnson • ALK-Abello • UCB • Kyowo Hako Kirin • Stallergenes Greer
A company profile gives you the following information where available: • Discussion of a company’s activities and outlook • Historic revenue, analysis and discussion of company performance • Analysis of major products currently on the market • Acquisitions and strategic partnerships
Discover capabilities, progress, and commercial prospects, helping you stay ahead.
What issues will affect the allergic rhinitis drugs industry? Our new report discusses issues and events affecting the allergic rhinitis drugs market. You will find discussions, including qualitative analyses: • Highly competitive market with significant variations in different geographic regions • Changing political and regulatory landscape changing the prospects of future products and reimbursement opportunities • Future paradigm-shifting pipeline products • Patent expirations and invalidations of major drugs • Launches of new drug categories
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.
Allergic Rhinitis Drugs Market Forecast 2016-2026: Analysis of the Current Trend and Pipeline Opportunities in the Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, and Immunotherapy and Vaccines Markets, Including Current Products such as Patanase, Dymista, Nasonex, Allegra, and Staloral with Assessment of Key Companies in the Allergic Rhinitis Market Including GSK and Merck & Co. In summary, our 240-page report gives you the following knowledge: • Revenue forecasts to 2026 for the Allergic Rhinitis Drugs market – discover the industry’s prospects, finding promising places for investments and revenues • Revenue forecasts to 2026 for each major submarket – discover prospects for leading allergic rhinitis drugs in the following areas: intranasal corticosteroids, intranasal antihistamines, oral antihistamines, and immunotherapy and vaccines. • Detailed profiles or revenue forecasts to 2026 for 25 of the leading products in the allergic rhinitis drugs market – discover prospects for leading allergic rhinitis drugs: Patanase, Astepro, Astelin, Dymista, Nasonex, Avamys, Veramyst, Fixonase, Rhinocort, Omnaris, Nasacort, Beconase, Qnasl, Zetonna, Allegra, Zyrtec, Claritin, Xyzal, Allelock, Clarinex, Ebastel, Talion, Staloral, Alutard SQ, Grazax, Ragwitek. • Revenue forecasts to 2026 for eleven leading national markets and one leading regional markets – US, EU5, China, Japan, India, Russia, and Brazil. • Assessment of eight leading companies – analysis of products, revenue, mergers & acquisitions, product type and product pipelines • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the over the counter medicine market and leading companies. You will find data, trends and predictions. Please order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global Allergic Rhinitis Drugs: Market Overview 1.2 Global Allergic Rhinitis Drugs Market Segmentation 1.3 Overview of Findings 1.4 Structure of the Report 1.5 Why You Should Read This Report 1.6 How This Report Delivers 1.7 Key Questions Answered by This Analytical Report 1.8 Who is This Report For? 1.9 Methodology 1.10 Frequently Asked Questions (FAQ) 1.11 Associated Visiongain Reports 1.12 About Visiongain
2. An Introduction to Allergic Rhinitis Drugs 2.1 The Pharmaceutical Industry: A Brief Introduction 2.1.1 Allergic Rhinitis Treatments – An Industry Overview 2.2 A Brief Overview of Allergy 2.3 Allergic Rhinitis 2.3.1 The Global Prevalence of Allergic Rhinitis 2.3.2 Pathophysiology of Allergic Rhinitis: IgEs and Mast Cells 2.3.3 Symptoms of Allergic Rhinitis 2.3.4 Classification of Allergic Rhinitis 2.3.4.1 Non-Allergic Rhinitis and Mixed Rhinitis 2.3.5 Seasonal Allergic Rhinitis (Hay Fever) 2.3.6 Perennial Allergic Rhinitis 2.3.7 Diagnosis of Allergic Rhinitis 2.4 Treatment of Allergic Rhinitis 2.4.1 Antihistamines 2.4.1.1 First-Generation Antihistamines 2.4.1.2 Second- And Third-Generation Antihistamines 2.4.2 Corticosteroids 2.4.2.1 First-, Second- And Third-Generation Intranasal Corticosteroids 2.4.2.2 Combination Drug Products 2.4.3 Leukotriene Receptor Antagonists 2.4.4 Cromolyn (cromoglicic acid) 2.4.5 Decongestants 2.4.6 Saline Nasal Sprays 2.4.7 Immunotherapy and Vaccines 2.5 Phases of Clinical Trials 2.6 Scope of this Report
3. The Global Allergic Rhinitis Drugs Market, 2016-2026 3.1 The Global Allergic Rhinitis Drugs Market: Market Overview 3.2 Categorisation Of The Global Allergic Rhinitis Drugs Market 3.3 The Global Allergic Rhinitis Drugs Market in 2015 3.4 The Global Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 3.5 Allergic Rhinitis Drugs: Changing Market Shares by Sector 2016-2026
4. Oral Antihistamines Market: Market Analysis And Forecast 2016-2026 4.1 Oral Antihistamines: Market Overview 4.1.1 Leading Products in the Oral Antihistamines Market, 2015 4.2 Oral Antihistamines: Market Trends and Developments, 2016 4.2.1 Patent Expiries and the Threat of Generics 4.2.2 The Increasing Switch from Prescription to Over-The-Counter Sales 4.2.3 The Potential for Combination Therapy with Intranasal Corticosteroids 4.3 Oral Antihistamines: Market Forecast 2016-2026 4.3.1 Oral Antihistamines: Changing Market Shares by Leading Drugs 2016-2026 4.4 Leading Oral Antihistamines for the Treatment of Allergic Rhinitis 4.4.1 Allegra/Allegra-D/Allegra OTC (fexofenadine) - Sanofi 4.4.1.1 Allegra/Allegra OTC: Historical Sales, 1995-2014 4.4.1.2 Allegra/Allegra OTC: Sales Forecast 2015-2026 4.4.2 Claritin/Claritin OTC (loratadine) – Bayer/ Merck & Co 4.4.2.1 Claritin/Claritin OTC: Sales Forecast 2016-2026 4.4.3 Zyrtec/Zyrtec D (cetirizine) - Johnson & Johnson/ UCB/ GSK 4.4.3.1 Zyrtec/Zyrtec D: Sales Forecast 2016-2026 4.4.5 Xyzal (levocetirizine) - Sanofi/ UCB/ GSK 4.4.5.1 Xyzal: Sales Forecast 2016-2026 4.4.6 Clarinex (desloratadine) - Merck & Co. 4.4.6.1 Clarinex: Sales Forecast 2016-2026 4.4.7 Allelock (olopatadine) - Kyowa Hakko Kirin 4.4.7.1 Allelock: Sales Forecast 2016-2026 4.4.8 Ebastel (ebastine) - AstraZeneca/Takeda/Dainippon Sumitomo 4.4.8.1 Ebastel: Sales Forecast 2016-2026 4.4.9 Talion (bepotastine) - Mitsubishi Tanabe 4.4.9.1 Talion: Sales Forecast 2016-2026 4.4.10 Other Oral Antihistamines: Sales Forecast 2016-2026
8. Leading National Markets for Allergic Rhinitis Drugs, 2016-2026 8.1 The Allergic Rhinitis Drugs Market by Region 8.1.1 The Global Distribution of Allergic Rhinitis Drugs in 2015 8.2 Leading National Markets: Forecast 2016-2026 8.2.1 Changing Market Shares by Region, 2016-2026 8.3 Regional Allergic Rhinitis Drugs Markets: Analysis and Forecasts, 2016-2026 8.3.1 United States: The Largest Allergic Rhinitis Drugs Market 8.3.1.1 US Allergic Rhinitis Drugs Market: Trends and Developments 8.3.1.1.1 The Trend of Rx-to-OTC Switching 8.3.1.2 US Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 8.3.2 EU5 8.3.2.1 EU5 Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 8.3.2.2 EU5 Markets: Changing Market Shares by Country, 2016-2026 8.3.2.3 Germany 8.3.2.3.1 Germany: Reform of AMNOG Pharmaceutical Rebate Law 8.3.2.3.2 German Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 8.3.2.4 UK 8.3.2.4.1 UK: Increasing Burden of Allergy 8.3.2.4.2 UK Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 8.3.2.5 France 8.3.2.5.1 France: Social Security Finance Act 2015 8.3.2.5.2 French Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 8.3.2.6 Italy 8.3.2.6.1 Italy: Government Cost Cutting Measures Impacting Market Growth 8.3.2.6.2 Italian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 8.3.2.7 Spain 8.3.2.7.1 Spanish Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 8.6 China 8.6.1 Air Pollution Associated With Increasing Prevalence 8.6.2 Expansion of Healthcare Coverage and Reimbursement in China 8.6.3 Chinese Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 8.7 Japan 8.7.1 Cedar Reforestation and the Hay Fever Epidemic 8.7.2 Genetically Modified Rice as Immunotherapy 8.7.3 Effects of the Rising Levels of Generic Drug Penetration 8.7.4 Japanese Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 8.8 Russia 8.8.1 How Will Russia’s Economic Status Affect Its Pharma Industry? 8.8.2 Russian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 8.9 India 8.9.1 The Impact of the Drug Prices Control Order on Indian Pharma 8.9.2 India’s Expansion of Healthcare Provision 8.9.3 Indian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 8.10 Brazil 8.10.1 How Will Brazil’s Growing Healthcare Influence Allergic Rhinitis Drugs 8.10.2 Brazilian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 8.12 Rest of the World 8.12.1 Rest of the World Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
9. Leading Companies in the Allergic Rhinitis Drugs Market, 2016-2026 9.1 Allergic Rhinitis Drugs – An Evolving Market Space 9.1.1 Leading Companies in the Allergic Rhinitis Drugs Market, 2016 9.2 ALK-Abelló 9.2.1 ALK-Abelló: Allergic Rhinitis Drugs Portfolio, 2016 9.2.2 ALK-Abelló: Recent Developments 9.2.2.1 Acarizax Launched in Europe progressing to International Roll-Out 9.2.2.2 ALK Collaborates With EddingPharm to Boost China Sales 9.2.2.3 ALK-Abelló: Sales Forecast 2016-2026 9.2.2.4 ALK-Abelló: Allergic Rhinitis Drug Development Pipeline, 2016 9.3 GlaxoSmithKline (GSK) 9.3.1 GlaxoSmithKline: Allergic Rhinitis Drugs Portfolio, 2016 9.3.2 GlaxoSmithKline: Sales Forecast 2016-2026 9.4 Johnson & Johnson 9.4.1 Johnson & Johnson: Allergic Rhinitis Drugs Portfolio, 2016 9.4.2 Johnson & Johnson: Recent Developments 9.4.2.1 Manufacturing Recalls At McNeil Consumer Healthcare 9.4.2.2 Johnson & Johnson: Sales Forecast 2016-2026 9.5 Kyowa Hakko Kirin 9.5.1 Kyowa Hakko Kirin: Allergic Rhinitis Drugs Portfolio, 2015 9.5.2 Kyowa Hakko Kirin: Sales Forecast 2016-2026 9.6 Merck & Co. 9.6.1 Merck: Allergic Rhinitis Drugs Portfolio, 2016 9.6.2 Merck: Recent Developments 9.6.2.1 Bayer Acquires Merck’s Consumer Health Business 9.6.2.2 FDA Rejects Singulair OTC Switch 9.2.6.3 Merck: Sales Forecast 2016-2026 9.2.6.4 Merck: Allergic Rhinitis Drug Development Pipeline, 2016 9.7 Sanofi 9.7.1 Sanofi: Allergic Rhinitis Drugs Portfolio, 2016 9.7.2 Sanofi: Sales Forecast 2016-2026 9.8 Stallergenes Greer 9.8.1 Stallergenes: Allergic Rhinitis Drugs portfolio, 2015 9.8.2 Stallergenes Greer: Sales Forecast 2016-2026 9.8.3 Stallergenes Greer: Allergic Rhinitis Drug Development Pipeline, 2015 9.9 UCB 9.9.1 UCB: Allergic Rhinitis Drugs Portfolio, 2015 9.9.2 UCB: Sales Forecast 2016-2026 9.10 Other Leading Companies within the Allergic Rhinitis Drugs Market
10. Allergic Rhinitis Drugs: Research and Development Pipeline, 2016-2026 10.1 Trends and Developments in the Allergic Rhinitis Pipeline 10.2 The R&D Pipeline for Oral Antihistamines, 2016 10.2.1 Talion (bepotastine) - Mitsubishi Tanabe 10.2.2 ZPL-3893787 (histamine H4R antagonist) - Ziarco Pharma 10.3 The R&D Pipeline for Intranasal Corticosteroids, 2016 10.3.1 APC-3000 (HFA inhaled corticosteroid) - Adamis Pharmaceuticals 10.3.2 TBS-6 - Trimel Pharmaceuticals 10.4 The R&D Pipeline for Immunotherapy in Allergic Rhinitis, 2016 10.4.1 Actair (house dust mite SLIT; STG320) - Stallergenes/Shionogi & Co 10.4.2 AllerT (subcutaneous birch pollen immunotherapy) - Anergis 10.4.3 Depigoid Birch 5000 (birch pollen allergen extract, Leti Pharma 10.4.4 House Dust Mite SLIT-Tablet (MK-8237) - ALK-Abelló/Merck/Torii 10.4.5 Pollinex Quattro (subcutaneous immunotherapies) - Allergy Therapeutics 10.4.6 gp-ASIT+ (grass pollen allergen fragments) - Biotech Tools 10.4.7 Betula verrucosa (Bet v) 1 allergen – Stallergenes Greer 10.5 The R&D Pipeline for Other Allergic Rhinitis Drugs 10.5.1 S-555739 (prostaglandin D2 receptor antagonist) - Shionogi 10.5.2 DSP-3025/AZD-8848 (toll-like receptor 7 agonist) - Dainippon Sumitomo/ AstraZeneca 10.5.3 GSK2245035 (toll-like receptor 7 agonist) - GSK 10.5.4 HP-3060 (transdermal long-acting tape) - Hisamitsu 10.5.5 MRX-4 (anti-inflammatory agent) - Celsus Therapeutics
11. Qualitative Analysis of the Allergic Rhinitis Drugs Market, 2016-2026 11.1 Market Factors Influencing Allergic Rhinitis Drugs 11.2 SWOT Analysis Of The Global Allergic Rhinitis Drugs Market, 2016-2026 11.2.1 Strengths 11.2.1.1 OTC-Switch Facilitating Ease Of Consumer Access 11.2.1.2 The Established Role Of Allergic Rhinitis Drugs In Treatment 11.2.1.3 Allergic Rhinitis And The Rising Unmet Clinical Need 11.2.1.4 Rising Profile of Allergic Rhinitis In Various Regions Driving Healthcare Provision 11.2.2 Weaknesses 11.2.2.1 Intranasal Corticosteroids And Patients’ Satisfaction Rates 11.2.2.2 Increasing Penetration Of Generic Drug Products 11.2.2.3 The Challenge Raised By The Low Volume Of Pipeline Developments 11.2.3 Opportunities 11.2.3.1 Growth In Emerging Markets Outstripping Established Markets 11.2.3.2 Rx-to-OTC Switching And The Effects On Revenue Potential 11.2.3.3 Combination Drug Products Providing Rising Efficacy Profiles 11.2.3.4 The Emergence Of Immunotherapy In Allergic Rhinitis 11.2.4 Threats 11.2.4.1 Cost-Containment As A Growth Restraint 11.2.4.2 Rising Cost Of APIs And Manufacturing 11.2.4.3 Patent Expiries And The Resultant Loss Of Revenue 11.3 Porter’s Five Force Analysis of the Global Allergic Rhinitis Drugs Market, 2016-2026 11.3.1 Power of Buyers 11.3.2 Power Of Suppliers 11.3.3 Threat of Substitutes 11.3.4 Threat Of New Entrants 11.3.5 Rivalry Among Competitors
12. Conclusions 12.1 Overview of Current Market Conditions and Market Forecast, 2015-2026 12.2 Leading Sectors in the Allergic Rhinitis Drugs Market in 2015 12.3 Leading Regions in the Allergic Rhinitis Drugs Market in 2015 12.4 Leading Companies in the Allergic Rhinitis Drugs Market, 2015 12.5 What Does The Future Hold For Allergic Rhinitis Drugs?
Associated Reports Appendix A About Visiongain Appendix B Visiongain report evaluation form
List of Tables Table 1.1 Allergic Rhinitis Market Forecast by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026 Table 2.1 Leading Antihistamines for Allergic Rhinitis, 2015 Table 2.2 Leading Corticosteroids for Allergic Rhinitis, 2016 Table 2.3 Clinical Trial Phases Table 3.1 The Global Allergic Rhinitis Drugs Market: Revenue ($m) and Market Shares (%) by Sector, 2015 Table 3.2 The Global Allergic Rhinitis Drugs Market: Market Forecast ($m, AGR%, CAGR%), 2015-2026 Table 3.4 The Global Allergic Rhinitis Drugs Market: Market Share (%) by Sector, 2015, 2020, 2026 Table 4.1 Leading Oral Antihistamines: Revenue ($m) and Market Share (%), 2015 Table 4.2 Oral Antihistamines Market Forecast: Revenue($m), AGR (%) and CAGR (%), 2015-2026 Table 4.3 The Global Oral Antihistamines Market: Market Share (%), 2015, 2020, 2026 Table 4.4 Allegra/Allegra-D/Allegra OTC Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 4.5 Claritin/Claritin OTC Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 4.6 Zyrtec/Zyrtec-D Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 4.7 Xyzal Forecast: Revenue($m), AGR (%) and CAGR (%), 2015-2026 Table 4.8 Clarinex Forecast: Revenue($m), AGR (%) and CAGR (%), 2015-2026 Table 4.9 Allelock Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 4.10 Ebastel Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 4.11 Talion Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 4.12 Other Oral Antihistamines Forecast: Revenue($m), AGR (%) and CAGR (%), 2015-2026 Table 5.1 Leading Drugs In The Intranasal Corticosteroids Market: Revenue ($m) and Market Shares (%), 2015 Table 5.2 Intranasal Corticosteroids Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026 Table 5.3 The Global Intranasal Corticosteroids Market: Market Share (%), 2015, 2020, 2026 Table 5.4 Flixonase/Flonase/Flonase-OTC Forecast: Revenue ($m), AGR (%), and CAGR (%), 2015-2026 Table 5.5 Nasonex Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 5.6 Avamys/Veramyst Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 5.7 Rhinocort: Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 5.8 Nasacort/Nasacort-OTC Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 5.9 Omnaris Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 5.10 Beconase/Beconase AQ Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 5.11 Qnasl Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 5.12 Zetonna Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 6.1 Leading Allergic Rhinitis Immunotherapy Products: Revenue ($m) and Market Share (%), 2015 Table 6.2 Allergic Rhinitis Immunotherapy Forecast: Revenue($m), AGR (%) and CAGR (%), 2015-2026 Table 6.3 The Global Allergic Rhinitis Immunotherapy Market: Market Share (%), 2015, 2020, 2026 Table 6.4 Allergic Rhinitis Immunotherapy Market by Type: Revenue ($m) and Market Share (%), 2015 Table 6.5 Staloral Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 6.6 Alutard SQ Forecast: Revenue($m), AGR (%) and CAGR (%), 2015-2026 Table 6.7 Grazax/Grastek Forecast: Revenue($m), AGR (%) and CAGR (%), 2015-2026 Table 6.8 Oralair Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 6.9 Ragwitek Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 6.10 Other Allergic Rhinitis Immunotherapy Products Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 7.1 Top Drugs In The Intranasal Antihistamines Market: Revenue ($m) and Market Shares (%), 2015 Table 7.2 Intranasal Antihistamines Market Forecast by Leading Drugs: Revenue ($m), AGR (%), and CAGR%), 2015-2026 Table 7.3 The Global Intranasal Antihistamines Market by Leading Drugs: Market Share (%), 2015, 2020, 2026 Table 7.4 Dymista (Meda Pharma) Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 7.5 Generic Intranasal Azelastine Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 7.6 Astepro Forecast; Revenue ($m), AGR (%) and CAGR (%), 2015-2025 Table 7.7 Patanase Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 7.8 Astelin Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 8.1 The Global Allergic Rhinitis Drugs Market by Region: Revenue ($m) and Market Share (%), 2015 Table 8.2 Global Allergic Rhinitis Drugs Market Forecast by Region: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 8.3 The Global Allergic Rhinitis Drugs Market Forecast by Region: Market Share (%), 2015, 2020, and 2026 Table 8.4 US Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 8.5 The EU5 Allergic Rhinitis Drugs Market Forecast by Country: Revenue ($m) and Market Share (%), 2015 Table 8.6 The EU5 Allergic Rhinitis Drugs Market Forecast: Revenue($m), AGR (%) and CAGR (%), 2015-2026 Table 8.7 The EU5 Allergic Rhinitis Drugs Market by Country: Market Share (%), 2015, 2020, 2026 Table 8.8 German Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 8.9 UK Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 8.10 French Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%), and CAGR (%), 2015-2026 Table 8.11 Italian Allergic Rhinitis Drugs Market Forecat: Revenue ($m), AGR (%), and CAGR (%), 2015-2026 Table 8.12 Spanish Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%), and CAGR (%), 2015-2026 Table 8.13 Chinese Allergic Rhinitis Drugs Market Forecast: Revenue($m), AGR (%) and CAGR (%), 2015-2026 Table 8.14 Japanese Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%), and CAGR (%), 2015-2026 Table 8.15 Russian Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 8.16 Indian Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 8.17 Brazilian Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 8.18 Rest of the World Allergic Rhinitis Drugs Market Forecast: Revenue($m), AGR (%) and CAGR (%), 2015-2026 Table 9.1 Leading Companies In The Allergic Rhinitis Drug Market: Revenues ($m) and Market Shares (%), 2015 Table 9.2 ALK- Abelló: Company Overview, 2016 Table 9.3 ALK-Abelló: Allergic Rhinitis Drugs Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 9.4 GlaxoSmithKline: Company Overview, 2016 Table 9.5 GlaxoSmithKline: Allergic Rhinitis Drugs Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 9.6 Johnson & Johnson: Company Overview, 2016 Table 9.7 Johnson & Johnson Allergic Rhinitis Drugs Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 9.8 Kyowa Hakko Kirin: Company Overview, 2016 Table 9.9 Kyowa Hakko Kirin: Allergic Rhinitis Drugs Forecast: Revenue ($m), AGR (%) and CAGR(%), 2015-2026 Table 9.10 Merck & Co: Company Overview, 2016 Table 9.11 Merck & Co: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%, CAGR%), 2015-2026 Table 9.12 Sanofi: Company Overview, 2016 Table 9.13 Sanofi: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%, CAGR%), 2015-2026 Table 9.14 Stallergenes Greer: Company Overview, 2015 Table 9.15 Stallergenes Greer: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%, CAGR%), 2015-2026 Table 9.16 UCB: Company Overview, 2016 Table 9.17 UCB: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%, CAGR%), 2015-2026 Table 11.1 SWOT Analysis of the Global Allergic Rhinitis Drugs Market, 2016-2026
List of Figures Figure 1.1 Global Allergic Rhinitis Drugs Market: Market Sectors, 2015 Figure 2.1 Role of Mast Cells and IgE in Allergic Rhinitis, 2016 Figure 3.1 The Global Allergic Rhinitis Drugs Market: Revenue ($m) by Sector, 2015 Figure 3.2 The Global Allergic Rhinitis Drugs Market: Market Forecast ($m, AGR%) by Sector, 2015-2026 Figure 3.3 The Global Allergic Rhinitis Drugs Market: Market Share (%) by Sector, 2015 Figure 3.4 The Global Allergic Rhinitis Drugs Market: Market Share (%) by Sector, 2020 Figure 3.5 The Global Allergic Rhinitis Drugs Market: Market Share (%) by Sector, 2026 Figure 4.1 Leading Oral Antihistamines: Revenue ($m), 2015 Figure 4.2 Oral Antihistamines Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 4.3 The Global Oral Antihistamines Market: Market Share(%), 2015 Figure 4.4 The Global Oral Antihistamines Market: Market Share (%), 2020 Figure 4.5 The Global Oral Antihistamines Market: Market Share (%), 2026 Figure 4.6 Allegra (Allegra Rx and Allegra OTC) Historical Sales: Revenue ($m),1995-2015 Figure 4.7 Allegra/Allegra-D/Allegra OTC Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 4.8 Claritin/Claritin OTC Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 4.9 Zyrtec/Zyrtec-D Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 4.10 Xyzal Forecast: Revenue($m) and AGR (%), 2015-2026 Figure 4.11 Clarinex Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 4.12 Allelock Forecast: Revenue($m) and AGR (%), 2015-2026 Figure 4.13 Ebastel Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 4.14 Talion Forecast: Revenue($m) and AGR (%), 2015-2026 Figure 4.15 Other Oral Antihistamines Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 5.1 Leading Drugs In The Intranasal Corticosteroids Market: Revenue ($m), 2014 Figure 5.2 Intranasal Corticosteroids Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 5.3 The Global Intranasal Corticosteroids Market by Leading Drugs: Market Share (%), 2015 Figure 5.4 The Global Intranasal Corticosteroids Market by Leading Drugs: Market Share (%), 2020 Figure 5.5 The Global Intranasal Corticosteroids Market by Leading Drugs: Market Share (%), 2026 Figure 5.6 Flixonase/Flonase/Flonase-OTC Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 5.7 Nasonex Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 5.8 Avamys/Veramyst Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 5.9 Rhinocort Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 5.10 Nasacort/Nasacort-OTC Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 5.11 Omnaris Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 5.12 Beconase/Beconase AQ Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 5.13 Qnasl Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 5.14 Zetonna Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 6.1 Leading Allergic Rhinitis Immunotherapy Products: Revenue ($m), 2015 Figure 6.2 Allergic Rhinitis Immunotherapy Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 6.3 The Global Allergic Rhinitis Immunotherapy Market: Market Share (%), 2015 Figure 6.4 The Global Allergic Rhinitis Immunotherapy Market: Market Share (%), 2020 Figure 6.5 The Global Allergic Rhinitis Immunotherapy Market: Market Share (%), 2026 Figure 6.6 Allergic Rhinitis Immunotherapy Market: Market Share (%) by Immunotherapy Type, 2015 Figure 6.7 Staloral Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 6.8 Alutard SQ Forecast: Revenue($m) and AGR (%), 2015-2026 Figure 6.9 Grazax/Grastek Forecast: Revenue($m) and AGR (%), 2015-2026 Figure 6.10 Oralair Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 6.11 Ragwitek Forecast: Revenue ($m) and AGR (%), 201-2026 Figure 6.12 Other Allergic Rhinitis Immunotherapy Products Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 7.1 Top Drugs In The Intranasal Antihistamines Market: Revenue ($m), 2015 Figure 7.2 Intranasal Antihistamines Market Forecast: Revenue ($m), AGR (%), 2015-2026 Figure 7.3 The Global Intranasal Antihistamines Market by Leading Drugs: Market Share (%), 2015 Figure 7.4 The Global Intranasal Antihistamines Market by Leading Drugs: Market Share (%), 2020 Figure 7.5 The Global Intranasal Antihistamines Market by Leading Drugs: Market Share (%, 2026 Figure 7.6 Dymista (Meda Pharma) Forecast: Revenue ($m) and AGR(%), 2015-2026 Figure 7.7 Generic Intranasal Azelastine Forecast: Revenue ($m) and, AGR (%), 2015-2026 Figure 7.8 Astepro Forecast: Revenue ($m), and AGR (%), 2015-2026 Figure 7.9 Patanase Forecast: Revenue($m) and AGR (%), 2015-2026 Figure 7.10 Astelin Forecast: Revenue ($m), AGR (%), 2015-2026 Figure 8.1 The Global Allergic Rhinitis Drugs Market By Region: Revenue ($m), 2015 Figure 8.2 The Global Allergic Rhinitis Drugs Market Forecast by Region: Market Share (%), 2015 Figure 8.3 The Global Allergic Rhinitis Drugs Market Forecast by Region: Market Share (%), 2020 Figure 8.4 The Global Allergic Rhinitis Drugs Market Forecast by Region: Market Share (%), 2026 Figure 8.5 US Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 8.6 The EU5 Allergic Rhinitis Drugs Market by Country: Revenue ($m), 2015 Figure 8.7 The EU5 Allergic Rhinitis Drugs Market: Market Share (%), 2015 Figure 8.8 The EU5 Allergic Rhinitis Drugs Market: Market Share (%), 2020 Figure 8.9 The EU5 Allergic Rhinitis Drugs Market: Market Share (%), 2026 Figure 8.10 German Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 8.11 UK Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 8.12 French Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 8.13 Italian Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 8.14 Spanish Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 8.15 Chinese Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 8.16 Japanese Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 8.17 Russian Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 8.18 Indian Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 8.19 Brazilian Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 8.20 Rest of the World Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure9.1 Leading Companies In The Allergic Rhinitis Drug Market: Revenues ($m), 2015 Figure 9.2 ALK-Abelló: Allergic Rhinitis Drugs Forecast: Revenue ($m), AGR (%), 2015-2026 Figure 9.3 GlaxoSmithKline Allergic Rhinitis Drugs Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 9.4 Johnson & Johnson Allergic Rhinitis Drugs Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 9.5 Kyowa Hakko Kirin: Allergic Rhinitis Drugs Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 9.6 Merck & Co: Allergic Rhinitis Drugs Revenue Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 9.7 Sanofi: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%), 2014-2025 Figure 9.8 Stallergenes Greer: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%), 2015-2026 Figure 9.9 UCB: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%), 2015-2026 Figure 11.1 Porter’s Five Force Analysis of the Allergic Rhinitis Drugs Market, 2016
ActoGeniX Adamis Pharmaceuticals ALK- Abelló Allergy Medical UK Allergy Therapeutics Almirall Altana Pharma (Nycomed) Anergis Apotex AstraZeneca Atopix Therapeutics Barr Laboratories Bausch & Lomb Belcher Pharmaceuticals Biotech Tools Catalent Pharma Solutions Celsus Therapeutics Dainippon Sumitomo DBV Technologies Dr Reddy’s Laboratories Eddingpharm Eleventa Genzyme (Sanofi) GlaxoSmithKline Greer Laboratories Hisamitsu Pharmaceutical Co Hoechst AG Human Genome Sciences Intas Pharmaceuticals Johnson & Johnson Keldman Healthcare Kyowa Hakko Kirin Leti Pharma (Laboratorios Leti) Lupin Pharmaceuticals Meda Pharma Medpointe Inc (Meda Pharma) Merck & Co Mitsubishi Tanabe Pharma Mylan Nippon Paper Group Novartis Omega Pharma Perrigo Pfizer ProStrakan (Kyowa Hakko Kirin) Reckitt Benckiser Roxane Laboratories (Boehringer Ingelheim) Sanofi Schering-Plough (Merck) Shionogi & Co Ltd Stallergenes Sun Pharmaceuticals Sunovion Pharmaceuticals (Dainippon Sumitomo) Takeda Teva Pharmaceuticals Trimel Pharmaceuticals Ube Industries UCB ViiV Healthcare Wockhardt Ziarco Pharma
Organisations Mentioned in this Report Allergy & Asthma Network AllergyUK American Academy of Allergy, Asthma and Immunology (AAAAI) British Society for Allergy & Clinical Immunology (BSACI) [UK] Farmácia Popular [Brazil] Imperial College London International Nurses Group In Immunodeficiencies Japanese Ministry of Health, Labour and Welfare Les Entreprises Du Médicament (Leem) [France] National Development and Reform Commission (NDRC) [China] National Pharmaceutical Pricing Authority (NPPA) [India] PollenUK The Pharmaceutical Research and Manufacturers of America (PhRMA) The UK Health and Social Care Information Centre Université Libre de Bruxelles [Belgium] University of Leuven [Belgium] US Attorney’s Office for the Eastern District of Pennsylvania US Food and Drug Administration (FDA) World Allergy Organisation World Health Organisation (WHO)
Download sample pages
Complete the form below to download your free sample pages for Allergic Rhinitis Drugs Market Forecast 2016-2026
Download sample pages
Complete the form below to download your free sample pages for Allergic Rhinitis Drugs Market Forecast 2016-2026
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
Visiongain Publishes Cancer Diagnostics Market Report 2021-2031
Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.
Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030
The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.
Visiongain Publishes Cell-Based Assays Market Report to 2030
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.
Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031
The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
